Our Dual Lens Approach

BVGH works to solve major global health problems by finding the common ground between the needs of patients in poor countries and the pragmatic needs of companies.

Image
 
Image
  
  

US Biopharma: "Nearly 300 Vaccines in R&D"

04/24/2012
United States-based biopharmaceutical companies are developing nearly 300 vaccines for the prevention and treatment of a wide variety of diseases, according to new industry data, PharmaTimes reports. Read more
 
print